Foundation therapies for heart failure in end stage kidney disease with Dr Matt Graham-Brown

Learning Objectives:
Review the scale of the problems - prevalence of HF syndromes in ESKD
Review current guidelines that guide practice and underpinning evidence
Discuss potential best practice for treating HF syndromes in this population

Dr. Matt Graham-Brown is a Clinical Associate Professor of Renal Medicine at the University of Leicester and Honorary Consultant Nephrologist at the University Hospitals of Leicester UK. His research has focused on cardiovascular disease in CKD, particularly the of advanced imaging to identify clinically relevant pathology and testing lifestyle interventions that may improve cardiovascular health. Increasingly his work has focused on the implementation of evidence-based practice, particularly optimization of lifestyle and pharmacotherapy in early-stage CKD and cardiovascular renal metabolic conditions.

Видео Foundation therapies for heart failure in end stage kidney disease with Dr Matt Graham-Brown канала Ottawa Nephrology